InfanDx

InfanDx

InfanDx developing a new generation of diagnostic tests for the care of neonates.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD41—61m (Dealroom.co estimates Jul 2021.)
Company register number HRB 70522 (Köln)
Cologne Nordrhein-Westfalen (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2010
Profit(<1m)
  • Edit
DateInvestorsAmountRound

$5.9m

Early VC

€6.0m

Series A
Total FundingAUD19.3m

Recent News about InfanDx

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.